Quest Diagnostics Income from Continuous Operations 2010-2024 | DGX
Quest Diagnostics annual/quarterly income from continuous operations history and growth rate from 2010 to 2024. Income from continuous operations can be defined as a company's total income or loss before discontinued operations, extraordinary items, preferred stock dividends and accounting change
- Quest Diagnostics income from continuous operations for the quarter ending September 30, 2024 was $0.237B, a 0% increase year-over-year.
- Quest Diagnostics income from continuous operations for the twelve months ending September 30, 2024 was $890M, a 8.67% increase year-over-year.
- Quest Diagnostics annual income from continuous operations for 2023 was $0.908B, a 10.54% decline from 2022.
- Quest Diagnostics annual income from continuous operations for 2022 was $1.015B, a 51.2% decline from 2021.
- Quest Diagnostics annual income from continuous operations for 2021 was $2.08B, a 38.76% increase from 2020.
Quest Diagnostics Annual Income from Continuous Operations
(Millions of US $) |
| 2023 |
$908 |
| 2022 |
$1,015 |
| 2021 |
$2,080 |
| 2020 |
$1,499 |
| 2019 |
$886 |
| 2018 |
$788 |
| 2017 |
$824 |
| 2016 |
$696 |
| 2015 |
$753 |
| 2014 |
$587 |
| 2013 |
$848 |
| 2012 |
$666 |
| 2011 |
$494 |
| 2010 |
$745 |
| 2009 |
$767 |
Quest Diagnostics Quarterly Income from Continuous Operations
(Millions of US $) |
| 2024-09-30 |
$237 |
| 2024-06-30 |
$240 |
| 2024-03-31 |
$208 |
| 2023-12-31 |
$205 |
| 2023-09-30 |
$237 |
| 2023-06-30 |
$249 |
| 2023-03-31 |
$217 |
| 2022-12-31 |
$116 |
| 2022-09-30 |
$276 |
| 2022-06-30 |
$250 |
| 2022-03-31 |
$373 |
| 2021-12-31 |
$413 |
| 2021-09-30 |
$527 |
| 2021-06-30 |
$650 |
| 2021-03-31 |
$490 |
| 2020-12-31 |
$609 |
| 2020-09-30 |
$591 |
| 2020-06-30 |
$193 |
| 2020-03-31 |
$106 |
| 2019-12-31 |
$265 |
| 2019-09-30 |
$226 |
| 2019-06-30 |
$219 |
| 2019-03-31 |
$176 |
| 2018-12-31 |
$139 |
| 2018-09-30 |
$227 |
| 2018-06-30 |
$233 |
| 2018-03-31 |
$189 |
| 2017-12-31 |
$267 |
| 2017-09-30 |
$175 |
| 2017-06-30 |
$207 |
| 2017-03-31 |
$175 |
| 2016-12-31 |
$167 |
| 2016-09-30 |
$205 |
| 2016-06-30 |
$209 |
| 2016-03-31 |
$115 |
| 2015-12-31 |
$200 |
| 2015-09-30 |
$354 |
| 2015-06-30 |
$129 |
| 2015-03-31 |
$70 |
| 2014-12-31 |
$195 |
| 2014-09-30 |
$139 |
| 2014-06-30 |
$142 |
| 2014-03-31 |
$111 |
| 2013-12-31 |
$151 |
| 2013-09-30 |
$412 |
| 2013-06-30 |
$161 |
| 2013-03-31 |
$124 |
| 2012-12-31 |
$149 |
| 2012-09-30 |
$167 |
| 2012-06-30 |
$184 |
| 2012-03-31 |
$166 |
| 2011-12-31 |
$186 |
| 2011-09-30 |
$182 |
| 2011-06-30 |
$172 |
| 2011-03-31 |
$-46 |
| 2010-12-31 |
$161 |
| 2010-09-30 |
$208 |
| 2010-06-30 |
$204 |
| 2010-03-31 |
$171 |
| 2009-12-31 |
$191 |
| 2009-09-30 |
$201 |
| 2009-06-30 |
$198 |
| 2009-03-31 |
$177 |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical - Outpatient & Home Care |
$17.988B |
$9.252B |
|
Quest Diagnostics, Inc. is the provider of commercial laboratory services. Quest provides lab testing services to physicians, hospitals, managed care organizations, employers, government institutions and other clinical laboratories. The company consists of 2 business groups - Diagnostic Information Services and Diagnostic Solutions. The company's focus is on two elements - to accelerate growth and to drive operational excellence. Restore Growth: The company has adopted seven tactical approaches to accelerate growth such as sales and marketing; development of esoteric testing through a disease focus; partnerships with hospitals and successful testing of international IDNs; creation of value from information assets; leadership in companion diagnostics; extension into adjacent markets. Drive Operational excellence: The company plans to focus on four strategic requirements - to enhance end-to-end customer value chain, enterprise information technology architecture, business performance tools and cost excellence.
|
